Literature DB >> 10369108

Serum cystatin C as an endogenous marker of the renal function--a review.

E Randers1, E J Erlandsen.   

Abstract

Since 1985, cystatin C has been suggested to be a marker of the renal function. Cystatin C is a proteinase inhibitor with a low molecular weight (M(r) = 13359). It is produced at a constant rate in all nucleated cells investigated to date, freely filtered in the renal glomeruli and reabsorbed and catabolised in the proximal tubules. The concentration of serum cystatin C is mainly determined by glomerular filtration, which makes cystatin C an endogenous marker of glomerular filtration rate (GFR). There are few data describing the influence of various factors on the production and elimination of cystatin C. Fully automated assays using particle-enhanced turbidimetry or particle-enhanced nephelometry are available and the assays are precise, rapid and usable in clinical routine practice. Reference intervals have been determined for cystatin C in adults and in children older than one year. It has been suggested that the same reference interval can be used in children older than one year and in adults without gender differences, on the assumption that the same method with the same standardisation is used. Several studies including adults and children with different renal diseases with various kidney function have suggested serum cystatin C to be a better marker of GFR than serum creatinine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369108     DOI: 10.1515/CCLM.1999.064

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  85 in total

1.  Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C?

Authors:  E S Kilpatrick; B G Keevil; G M Addison
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).

Authors:  Michelle M Estrella; Brad C Astor; Anna Köttgen; Elizabeth Selvin; Josef Coresh; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

3.  Use of serum cistatin C determination as a marker of renal function in the dog.

Authors:  M T Antognoni; D Siepi; F Porciello; G Fruganti
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

4.  Thyroid function differently affects serum cystatin C and creatinine concentrations.

Authors:  L Manetti; E Pardini; M Genovesi; A Campomori; L Grasso; L L Morselli; I Lupi; G Pellegrini; L Bartalena; F Bogazzi; E Martino
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

5.  Serum cystatin-C evaluation in dogs affected by different diseases associated or not with renal insufficiency.

Authors:  M T Antognoni; D Siepi; F Porciello; F Rueca; G Fruganti
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

6.  Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn.

Authors:  Milena Treiber; Breda Pecovnik-Balon; Maksimiljan Gorenjak
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

7.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

8.  Evaluation of serum cystatin-C in dogs with visceral leishmaniasis.

Authors:  S Pasa; G Bayramli; A Atasoy; A Karul; S Ertug; S Ozensoy Toz
Journal:  Vet Res Commun       Date:  2009-01-13       Impact factor: 2.459

Review 9.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

10.  Serum sclerostin levels in healthy men over 50 years of age.

Authors:  Harjit Pal Bhattoa; John Wamwaki; Edit Kalina; Roza Foldesi; Adam Balogh; Peter Antal-Szalmas
Journal:  J Bone Miner Metab       Date:  2013-03-24       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.